Effects of Dapagliflozin in Asian patient with HFrEF in DAPA-HF

Kieran F. Docherty, MB CHB, Inder S. Anand, MD, DPHIL, Chern-En Chiang, MD, PHD, Vijay K. Chopra, MD, Akshay S. Desai, MD, Masafumi Kitakaze, MD, PHD, Subodh Verma, MD, PHD, Pham N. Vinh, MD, PHD, Silvio E. Inzucchi, MD, Lars Køber, MD, DMSC,  Mikhail N. Kosiborod, MD, Felipe A. Martinez, MD, Olof Bengtsson, PH LIC, Piotr Ponikowski, MD, PHD, Marc S. Sabatine, MD, MPH, Mikaela Sjöstrand, MD, PHD, Scott D. Solomon, MD, Anna Maria Langkilde, MD, PHD, Pardeep S. Jhund, MBCHB, MSC, PHD, John J.V. McMurray, MD. Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF. https://doi.org/10.1016/j.jacasi.2022.02.004

Effects of Dapagliflozin in Asian patient with HFrEF in DAPA-HF